Sign Up
Stories
Biotech Collaboration for Innovative Solutions
Share
Advancements in Gene Editing and Cancer ...
Biopharma Breakthroughs and Safety Advan...
Biotech Collaboration Enhances CRISPR In...
4DMT Presents Positive Interim Data
Biotech Collaboration Enhances Sector So...
Biotech Collaboration for Industry Innov...
Overview
API
Modalis Therapeutics partners with Ginkgo Bioworks, granting access to CRISPR-GNDM® technology for diverse sectors.
Ask a question
How does the partnership reflect the growing importance of synthetic biology in various sectors?
How might the partnership influence advancements in gene therapy and agriculture?
What potential impact could this collaboration have on the pharmaceutical industry?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jan 2024
Feb 2024
Mar 2024
Coverage